RÉSUMÉ
The habitual consumption of snacks has the potential to enrich or harm the diet. They can contribute to excessive caloric intake and hyperglycemia. Thus, there is an increasing interest in snacks with health-promoting properties. This study aimed to demonstrate the beneficial effect of two fruit-based bars on glucose levels through in vitro, in vivo, and in silico assays. Mango (Mangifera indica L.) and pineapple (Ananas comosus L.) bars (MB and PB) were prepared, and chemical composition, postprandial glycemic response, glycemic index (GI), and glycemic load (GL) were evaluated. The inhibitory effect of fruit bar extracts on α-amylase and α-glucosidase activity and their respective molecular docking was assessed. MB and PB showed the lowest postprandial glycemic response vs. the control bar (p < 0.005), a lower GI (CB: 64.20, PB: 53.20, MB: 40.40), and a GL of 10.9 (CB), 7.9 (PB), and 6.1 (MB), (p < 0.05). MB and PB showed the highest inhibition % of α-amylase (61.44 and 59.37%, respectively) and α-glucosidase (64.97 and 64.57%). Naringenin (-1692.5985 and -2757.674 kcal/mol) and ferulic acid (-1692.8904 and -2760.3513 kcal/mol) exhibited more favorable interaction energies against α-amylase and α-glucosidase activity. The presence of polyphenols from the fruit influenced enzymatic inhibition. Likewise, the dietary fiber in the bars evaluated allowed us to observe a positive effect that favors glycemic control, making them a healthy alternative for snacking.
RÉSUMÉ
The consumption of dietary fiber (DF) has been associated with a reduced incidence of non-communicable diseases. Despite various strategies implemented worldwide to increase DF intake, it remains low. Therefore, the development of new fiber-rich food products that are widely consumed could be a strategy to improve DF intake. In this study, an agro-industrial by-product, pomegranate peel powder (PPP), was used as an innovative source of DF and antioxidant. The objective was to develop a bread enriched with DF, antioxidants, and sensory characteristics by partially replacing wheat flour (WF) with PPP at levels of 0%, 2.5%, 5%, 7.5%, and 10%. Bread with 2.5% and 5% PPP was chosen for a clinical trial to evaluate glycemic response (GR) in healthy subjects and determine the bread's glycemic index (GI). As the percentage of PPP increased, both the DF and total polyphenol content increased significantly. The highest overall acceptability was achieved with bread containing up to 5% PPP. Consumption of bread with 2.5% and 5.0% PPP significantly reduced the GI compared to the control bread, while the decrease in GR was not significant. PPP could be a potential food and low-cost ingredient to improve the bread's nutritional quality through its contribution to DF and antioxidants.
RÉSUMÉ
PURPOSE: Resistant starch (RS) content has exhibited beneficial effects on glycemic control; however, few studies have investigated the effects of this substance on postprandial responses and appetite in subjects with type 2 diabetes (T2D). Here, we aimed to examine the effects of RS from two sources on glycemic response (GR), postprandial lipemia, and appetite in subjects with T2D. METHODS: In a randomized and crossover study, 17 subjects with T2D consumed native banana starch (NBS), high-amylose maize starch (HMS) or digestible maize starch (DMS) for 4 days. On day 5, a 6-h oral meal tolerance test (MTT) was performed to evaluate glycemic and insulinemic responses as well as postprandial lipemia. Besides, subjective appetite assessment was measured using a visual analogue scale. RESULTS: NBS induced a reduction on fasting glycemia, glycemia peak and insulinemic response during MTT. However, no modifications on postprandial lipemia were observed after RS treatments. Both NBS and HMS reduced hunger and increased satiety. CONCLUSION: NBS supplementation induced more beneficial effects on glycemic metabolism than HMS even when all interventions were matched for digestible starch content. RS intake did not modify postprandial lipemia, however, positively affected subjective appetite rates. TRIAL REGISTRATION: This trial was retrospectively registered at www.anzctr.org.au (ACTRN12621001382864) on October 11, 2021.
Sujet(s)
Diabète de type 2 , Hyperlipidémies , Humains , Appétit , Amidon résistant/pharmacologie , Études croisées , Glycémie/métabolisme , Insuline , Amidon/métabolisme , Période post-prandialeRÉSUMÉ
Considering the challenges in meeting the high nutritional demand during ultramarathons, the aim of this study was to analyze the nutritional strategies and glycemic response of an athlete with type 1 diabetes (DM1) during participation in a 217-km ultramarathon. A 36-y-old male athlete who was diagnosed with DM1 15 y earlier was studied during participation in the Brazil 135 ultramarathon. Food consumption and blood glucose were recorded during the race, and nutritional intake was calculated after the race. The athlete completed the race in 51 h 18 min. He consumed a total of 15.0 MJ (3593 kcal), 532 g carbohydrate, 166 g protein, 92 g lipid, and 14 L of water during the race. Glycemic values ranged from 3.6 to 18.2 mmol·L-1. Most glycemic values (47%) ranged from 3.9 to 10 mmol·L-1, whereas 5% were <3.9 mmol·L-1, 16% were >10 to 13.9 mmol·L-1, and 32% were >13.9 mmol·L-1. This case report describes the dietary profile of an athlete with DM1 during a 217-km ultramarathon. Although the athlete implemented strategies that differed from those recommended in the literature, food and nutrient intake and the glycemic management strategy adopted allowed him to successfully finish the race. These results suggest that past personal experiences can be considered and that nutritional recommendations for athletes with DM1 should be individualized.
Sujet(s)
Diabète de type 1 , Athlètes , Glycémie , Régime alimentaire , Ration calorique , Humains , MâleRÉSUMÉ
Jabuticaba is a Brazilian berry rich in polyphenols, which may exert beneficial effects on metabolic diseases. This randomized crossover study aimed to determine the effects of jabuticaba juice (250 ml in a portion) on postprandial response. Sixteen healthy subjects (11 women; 5 men; 28.4 ± 3.8 years old; body mass index (BMI) 21.7 ± 2.3 kg m-2) consumed two test products after fasting overnight in a randomized controlled crossover design. Each test product portion had a similar composition of sugar components: 250 mL water with glucose, fructose, colored with artificial non-caloric food colorings (placebo); and 250 mL of jabuticaba juice. Beverages were administered immediately before a carbohydrate meal. Blood samples were collected at 0, 15, 30, 45, 60, 90, and 120 min after each test product to analyze the concentrations of glucose, insulin, C-peptide, antioxidant capacity, plasma glucagon-like peptide-1 (GLP-1), and appetite sensations. Compared to the placebo, the intake of jabuticaba juice resulted in a higher GLP-1 response as the area under the curve (AUC) and peaking at 60 min. Jabuticaba juice also resulted in higher antioxidant capacity. Postprandial glucose, insulin, C-peptide levels, and appetite sensations were not significantly different between tests. In conclusion, 250 mL of jabuticaba juice before a carbohydrate meal was able to improve the antioxidant status and GLP-1 concentrations in healthy subjects.
RÉSUMÉ
Glycemic Index (GI) is a measure of carbohydrate quality and is recognised as a valid and reproducible method of classifying carbohydrate foods according to its effects on postprandial glycaemia. In this randomised crossover trial (RBR-7rjx3k) we determined the GI of nine enteral formulas, following the Food and Agriculture Organisation/World Health Organisation method. Forty healthy participants were included in the study (85% female mean age 27.1 ± 6.7 years). GI of the enteral formulas ranged from 40.5 to 85.2; four formulas had high GI (Nutrienteral 1.5®, Novasource GI Control®, Diamax®, Isosource Soya®), two intermediate GI (Fresubin 1.2 HP Fibre®, Nutrison Energy Multifiber 1.5®) and three low GI (Trophic 1.5®, Glucerna®, Novasource GC HP®). The GI coefficient of variation ranged from 22.9% to 83.6%. The effect of the enteral formulas with low GI in glycemic control of patients with enteral nutrition prescription needs to be test in future studies.
Sujet(s)
Nutrition entérale , Indice glycémique , Adulte , Études croisées , Femelle , Humains , Mâle , Jeune adulteRÉSUMÉ
Introducción: el tratamiento de la diabetes tipo 1 (DM1) requiere de la administración de insulina exógena; dentro de las variables a tener en cuenta para calcular la dosis se encuentra el contenido de hidratos de carbono (HC) de la comida a ingerir. Este macronutriente es considerado, desde hace varios años, el responsable del aumento de la glucemia postprandial (GPP). El conteo de hidratos de carbono (CHC) es el método más aceptado y utilizado actualmente en el tratamiento nutricional, aunque cada vez existe más evidencia de que hay otros macronutrientes, como las proteínas y las grasas, que pueden influir en la variación de la GPP. Objetivo: el objetivo de esta revisión bibliográfica es reunir los resultados de publicaciones científicas que analizaron la respuesta glucémica (RG) al consumo de comidas con alto contenido de proteínas y grasas y hacer un análisis de las diferentes intervenciones. Materiales y método: búsqueda bibliográfica en PUBMED, inicialmente 196 artículos. Luego de aplicar los criterios de inclusión y exclusión se seleccionaron 26 artículos realizados en personas con DM1 de los últimos 10 años (2007-2017) referidos al consumo de comidas altas en proteínas y grasas. Resultados: hay una significativa variación interpersonal en los requerimientos de insulina en respuesta a las grasas y proteínas dietarias, que puede fluctuar en un 65% ± 10%. En los estudios randomizados se logró determinar que en las comidas altas en grasas el pico de GPP fue demorado y la sensibilidad a la insulina fue menor. Uno de los estudios logró demostrar que el 100% de las comidas altas en grasa se asociaron con hiperglucemia tardía. En relación a las dos revisiones sistemáticas encontradas, se hace hincapié en la búsqueda de datos para mejorar el tratamiento intensificado de la DM1, siendo el control de la GPP el indicador principal, ponderando la importancia de considerar la ingesta proteica y grasa de manera adicional al CHC. Conclusión: se concluye que el efecto de una comida con un alto contenido en proteínas y grasas sobre la glucemia suele presentarse entre las 3 a 6 hs de consumidas, siempre teniendo en cuenta la respuesta individual y el modo de administrar la insulina. La tarea del equipo interdisciplinario es fundamental para conocer la respuesta individual en el paciente con DM1 ante el consumo de comidas altas en proteínas y grasas, pudiendo así orientar la toma de decisión(AU).
Introduction: the treatment of type 1 diabetes (DM1) requires the administration of exogenous insulin, being the carbohydrate (HC) content of the meal to be ingested one of the variables to be considered to calculate the insulin dose. For several years, this macronutrient has been considered responsible for the increase in postprandial glycemia (PPG). Carbohydrate Counting (CHC) is the most accepted and currently used method in the nutritional treatment, although there is enough evidence that other macronutrients, such as protein and fat, can influence on the variation of PPG. Objective: to gather the results of scientific publications which analysed the glycemic response (GR) to the consumption of high-protein and high-fat meals and to analyse de different interventions. After applying the inclusion and exclusion criteria, 24 articles were selected including those with individuals with DM1 from the past 10 years (with the exception of one) referring to the consumption of high-protein and high-fat meals. Results: there is a significant interpersonal variation in insulin requirements in response to dietary fat and protein, which can fluctuate by 65% +/- 10%. Randomized studies showed that in the high-fat meals, the peak of PPG was delayed and insulin sensitivity was lower. One of the studies showed that 100% of high-fat meals were associated with late hyperglycemia. Both systematic reviews emphasize the need to search for data to improve the intensive treatment of DM1, with the control of PPG being the main indicator, considering protein and fat intake, in addition to CHC. Conclusion: the effect on blood glucose of high-protein and high-fat meals usually occurs between 3 to 6 hours after being consumed, always considering the individual response and the insulin administration method. The task of the interdisciplinary team is essential to know the individual response in the DM1 patient to the consumption of high-protein and high-fat meals, thus being able to guide the decision-making process(AU).
Sujet(s)
Protéines , Diabète de type 1 , GlucidesRÉSUMÉ
The metabolic effects of cranberry and blueberry consumption on glycemic control have been evaluated in vitro and in animal models as well as in human studies, although findings have not been systematically reviewed yet. Therefore, a systematic review was carried out of relevant randomized clinical trials (RCTs) in order to assess the effect of berries (blueberry and cranberry) consumption on type 2 diabetes (T2DM) glycemic control. Some evidences were also discussed on the anti-diabetic mechanisms exerted by berries polyphenols. Studies were identified by searching electronic databases: LILACS, PubMed/MEDLINE, Scopus, The Cochrane Library and Web of Science. Three authors independently searched and extracted RCTs in which the effect of berries (cranberry or blueberry) consumption on T2DM glycemic control was assessed. A total of 7 RCTs, involving 270 adults with type 2 diabetes were included. Despite the heterogeneity of the administration forms (in natura, dried, extract, preparations - juice), dosage, duration of the intervention and type of population of the studies involving these two berries some studies highlight the potential benefit of berries, especially of blueberry, on glucose metabolism in T2DM subjects. Daily cranberry juice (240 mL) consumption for 12 weeks and blueberry extract or powder supplementation (9.1 to 9.8 mg of anthocyanins, respectively) for 8 to 12 weeks showed a beneficial effect on glucose control in T2DM subjects. Those results indicate a promising use of these berries in T2DM management; although more studies are required to better understand the mechanisms involved.
Sujet(s)
Glycémie/effets des médicaments et des substances chimiques , Myrtillier/composition chimique , Diabète de type 2/diétothérapie , Fruit/composition chimique , Vaccinium macrocarpon/composition chimique , Animaux , Anthocyanes/usage thérapeutique , Thérapies complémentaires , Bases de données factuelles , Diabète de type 2/prévention et contrôle , Compléments alimentaires , Humains , Phytothérapie , Extraits de plantes/pharmacologie , Polyphénols/usage thérapeutique , Essais contrôlés randomisés comme sujetRÉSUMÉ
In vitro studies have shown that vacuum frying may be an effective process to reduce starch digestibility as it may limit gelatinization; this is significant as overconsumption of starchy foods contributes to obesity and type 2 diabetes. Although in vitro studies are an instrumental tool, in vivo studies allow observation of the overall effect on a living organism. The aim of this research was to assess how in vivo starch digestibility can be reduced when frying under vacuum (9.9â¯kPa), after feeding Sprague-Dawley rats, while also understanding its relationship to in vitro starch digestibility. Results showed that vacuum-fried dough has a lower degree of gelatinization (â¼53.8%) and a maximal blood glucose level at 60â¯min (slower glycemic response) than atmospheric counterparts (â¼98.3% degree of gelatinization and maximal blood glucose level at 30â¯min). Similarly, in vitro procedures exhibited less rapidly available glucose and higher unavailable glucose fractions in vacuum-fried dough.
Sujet(s)
Digestion , Manipulation des aliments/méthodes , Glucose/composition chimique , Animaux , Gélatine/composition chimique , Glucose/métabolisme , Mâle , Rats , Rat Sprague-Dawley , Amidon/composition chimique , Amidon/métabolisme , VideRÉSUMÉ
Existen fórmulas enterales específicas para mejorar el control glicémico en diabéticos; con carbohidratos cuya respuesta glicémica sería de interés indagar. Se determinó el efecto del consumo de una fórmula con carbohidratos de liberación prolongada sobre la respuesta glicémica e insulina post-prandial en 21 sujetos sanos; (11 hombres y 10 mujeres) entre (17 y 25 años), quienes consumieron en 2 ocasiones la fórmula enteral polimérica para diabéticos y el alimento de referencia (pan blanco), en una cantidad de 50 g de carbohidratos disponibles. La glicemia fue medida a los 0, 15, 30,45, 60, 75, 90, 105 y 120 min y las concentraciones de insulina en ayuno y a los 120 min. El área bajo la curva de glicemia fue calculada resultando más baja para la fórmula 11718,20. ± 1112,38 que para el pan blanco 13269,18 ± 1351,05, (p<0,001). El índice glicémico (IG) resultó intermedio (63,33±5,22), y más bajo al compararlo con los rangos de IG publicados para el alimento de referencia(80-96). Se produjo una menor concentración de glicemia posterior al consumo de la fórmula; sin incrementos en los requerimientos de insulina, presumiendo un uso adecuado en diabéticos y una respuesta de saciedad más prolongada. Este efecto y la hemoglobina glicosilada deberían estudiarse tras el consumo en períodos prolongados en sujetos con diabetes(AU)
There are specific formulas of enteral nutrition to improve glycemic control in diabetic patients containing different types of carbohydrates which glycemic response should be investigated. The consumption effect of a formula with carbohydrates with extended release was determined on the glycemic response and postprandial insulin in 21 healthy individuals (11 men and 10 women) from 17 to 25 years old, who consumed in two different time the polymeric enteral formula for diabetics and the reference food (white bread) in a quantity of 50 g of available carbohydrates. The glycemia was measured at 0, 15, 30, 45, 60, 75, 90, 105 and 120 min and the insulin concentrations in fasting and within 120 min. The area in the glycemic curve was measured being the lowest the formula 11718.20. ± 1112.38 than in white bread 13269.18 ± 1351.05 (P<0.001). The glycemic index (GI) resulted to be intermediate (63.33±5.22) and lower when compared to the GI ranks published for the reference food (80-96). A lower concentration of glycemia occurred after the consumption of the formula, without increments in the insulin requirements; thus, assuming an adequate use in diabetic and a more extended feeling of fullness. This effect and the glycated hemoglobin should be studied after the extended consumption in people with diabetes(AU)
Sujet(s)
Humains , Mâle , Femelle , Adolescent , Adulte , Glucides , Nutrition entérale , Indice glycémique , Insuline/analyse , Analyse chimique du sang , Techniques de laboratoire clinique , Diabète de type 2RÉSUMÉ
In real food, starch is usually forming part of a matrix with lipids and proteins. However, research on this ternary system and interactions between such food components has been scarce so far. The control of food microstructure is crucial to determine the product properties, including sensorial and nutritionals ones. This paper reviews the microstructural principles of interactions between starch, lipids, and proteins in foods as well as their effect on postprandial glycemic response, considering human intrinsic differences on postprandial glycemic responses. Several lines of research support the hypothesis that foods without rapidly digestible starch will not mandatorily generate the lowest postprandial glycemic response, highlighting that the full understanding of food microstructure, which modulates starch digestion, plays a key role on food design from a nutritional viewpoint.
Sujet(s)
Glycémie , Analyse d'aliment , Lipides/composition chimique , Protéines/composition chimique , Amidon/composition chimique , HumainsRÉSUMÉ
An abnormal glycemic profile, including postprandial glycemia and acute glucose spikes, precedes the onset of overt diabetes in obese subjects. Previous studies have shown the beneficial effects of chronic native banana starch (NBS) supplementation. In this study, we examined the effects of acute ingestion of NBS on glycemic profiles by means of continuous glucose monitoring in obese and lean subjects. In a crossover study, obese and lean subjects consumed beverages containing either 38.3 g of NBS or 38.3 g of digestible corn starch (DCS) twice daily during 4 days. On day 5, a 3-h meal tolerance test (MTT) was performed to evaluate glucose and insulin responses. After 1 week of washout period, treatments were inverted. NBS supplementation reduced the 48-h glycemia AUC in lean, obese, and in the combined group of lean and obese subjects in comparison with DCS. Postprandial glucose and insulin responses at MTT were reduced after NBS in comparison with DCS in all groups. However, no changes were observed in glycemic variability (GV) indexes between groups. In conclusion, acute NBS supplementation improved postprandial glucose and insulin responses in obese and lean subjects during 48 h of everyday life and at MTT. Further research to elucidate the mechanism behind these changes is required.
Sujet(s)
Glycémie/effets des médicaments et des substances chimiques , Musa , Obésité , Amidon/administration et posologie , Amidon/pharmacologie , Adolescent , Adulte , Études croisées , Diabète , Femelle , Humains , Insuline , Mâle , Adulte d'âge moyen , Monitorage physiologique , Période post-prandiale , Jeune adulteRÉSUMÉ
The objective was to determine the glycemic index and glycemic load of tropical fruits and the potential risk for chronic diseases.Nine fruits were investigated: coconut water (for the purpose of this study, coconut water was classified as a fruit), guava,tamarind, passion fruit, custard apple, hog plum, cashew, sapodilla, and soursop. The GI and GL were determined accordingto the Food and Agriculture Organization protocol. The GL was calculated taking into consideration intake recommendation guidelines; 77.8% of the fruits had low GI although significant oscillations were observed in some graphs, which may indicate potential risks of disease. Coconut water and custard apple had a moderate GI, and all fruits had low GL. The fruits evaluatedare healthy and can be consumed following the daily recommended amount. However, caution is recommended with fruitscausing early glycemic peak and the fruits with moderated GI (coconut water and custard apple).
Sujet(s)
Humains , Maladie chronique , Indice glycémique , Charge glycémique , FruitRÉSUMÉ
The impact of cyclodextrins (CDs) on postprandial glycemic response employing the real-time continuous glucose monitoring system (RT-CGMS) was investigated. For this purpose, α-CD, ß-CD, γ-CD, HP-ß-CD, curdlan, and dextrin at doses of 10 and 100 mg/kg were orally administered in rats. The RT-CGMS was efficient to evaluate the impact of CDs on postprandial glycemia. The results showed that α-CD, ß-CD, dextrin, and curdlan did not reduce the glycemic response after the administration of starch. In contrast, the HP-ß-CD (100 mg/kg) attenuated the rise in glycemia. Moreover, the γ-CD blunts the postprandial glycemic excursion at doses of 10 and 100 mg/kg. Therefore, γ-CD could attenuate the rise in glycemia promoted by oral administration of starch. Considering that the treatment of postprandial hyperglycemia is necessary to prevent type 2 diabetes, this study opens the perspective of better control of postprandial glycemia by the addition of γ-CD in food.
Sujet(s)
Glycémie/métabolisme , Cyclodextrines/usage thérapeutique , Hyperglycémie/prévention et contrôle , Hypoglycémiants/usage thérapeutique , Période post-prandiale , 2-Hydroxypropyl-beta-cyclodextrin , Animaux , Cyclodextrines/pharmacologie , Diabète de type 2/sang , Diabète de type 2/prévention et contrôle , Hyperglycémie/sang , Hypoglycémiants/pharmacologie , Mâle , Modèles animaux , Monitorage physiologique/méthodes , Rat Wistar , Amidon/sang , Cyclodextrines bêta/pharmacologie , Cyclodextrines bêta/usage thérapeutique , Cyclodextrines gamma/pharmacologie , Cyclodextrines gamma/usage thérapeutiqueRÉSUMÉ
OBJECTIVE: To evaluate the sensory acceptance and glycemic response of fresh tagliarini pasta made with passion fruit peel flour. METHODOLOGY: passion fruit peels were dried in the temperatures of 45 °C, 50 °C, and 55 °C, in triplicate. After triturated in a blender the lighter flour was submitted to chemical composition and microbial analyzes. Two recipes were then processed; one containing 25% and another with 35% of passion fruit peel flour. The other ingredients were: white wheat flour, egg, olive oil and water. After homogenization the mixes were worked in a cylinder and cut to obtain the tagliarini form. After cooking them, both tagliarini pastas passed through a sensory test with 130 untrained volunteers. The best formulation was selected for a glycemic response test, in which 20 volunteers received the equivalent of 50 g of carbohydrate; blood glucose levels were measured in the premeal and postprandial periods. RESULTS: The chemical composition analysis showed that fiber was the main flour component, and moisture content and microbiological quality were in compliance with the current legislation. The most accepted formulation (25%) was applied in a glycemic response test. The baseline blood glucose in the experimental group was 93.1 ± 5.31 mg/dL, while the control group was 90.55 ± 8.95 mg/dL. Thirty minutes after consuming the blood glucose, the average in the experimental group was 97.0 ± 9.8 mg/dL and remained constant until 2 hours following the pasta consumption. These values were significantly lower than the average blood glucose measured in the control group after 30 and 60 minutes. This group presented an increase in 19.8 ± 10.1 mg/dL and in 17.8 ± 14.5 mg/dL, respectively. CONCLUSION: The results suggest that passion fruit peel flour can be used in pasta in order to nutritionally fortify the product and help in the glycemic control
OBJETIVO: Avaliar a aceitação sensorial e resposta glicêmica de massa fresca tipo talharim formulada com farinha da casca do maracujá. METODOLOGIA: Cascas de maracujá foram desidratadas nas temperaturas de 45 °C, 50 °C e 55 °C, em triplicata, após trituração em liquidificador; a farinha de coloração mais clara foi submetida às análises de determinação da composição centesimal e microbiológica. Duas formulações de massas foram processadas por meio da mistura dos ingredientes: farinha de trigo sem fermento, ovo, farinha de maracujá nas proporções de 25% ou 35%, azeite e água. Depois da homogeneização, a mistura foi passada em cilindro para extrusão e, em seguida, cortada para obter a forma do talharim. Depois da cocção, as duas massas tipo talharim foram submetidas a teste sensorial com 130 provadores não treinados. A formulação de melhor aceitação foi selecionada para pesquisa da resposta glicêmica, na qual 20 voluntários receberam uma porção com o equivalente a 50 g de carboidrato; a glicemia foi aferida nos períodos pré-prandial e pós-prandial. RESULTADOS: As análises de composição química mostraram as fibras como principal componente, com umidade e qualidade microbiológica adequados à legislação vigente. A formulação de melhor aceitação (25%) foi aplicada para o teste glicêmico. A glicemia basal do grupo experimental foi 93,1 ± 5,31 mg/dL, e a do grupo controle 90,55 ± 8,95 mg/dL. Trinta minutos após a ingestão, a média do grupo experimental foi de 97,0 ± 9,8 mg/dL, mantendo-se constante até 2 horas depois. Esses valores foram mais baixos do que as médias aferidas no grupo controle após 30 e 60 minutos, sendo que esse grupo apresentou um incremento glicêmico de 19,8 ± 10,16 mg/dL e de 17,8 ± 14,49 mg/dL, respectivamente. CONCLUSÃO: Os resultados encontrados sugerem que farinha da casca do maracujá pode ser aplicada em massas alimentícias para auxiliar no controle glicêmico
Sujet(s)
Humains , Mâle , Femelle , Indice glycémique , Passiflora/métabolisme , Passiflora/physiologie , Pâtes AlimentairesRÉSUMÉ
Objetivos: Comparar las respuestas glucémicas e insulinémicas de dos desayunos, con la prueba estándar de tolerancia a la glucosa oral (PTGO). Métodos: En 14 sujetos sanos se realizó la PTGO, con 75 gr de glucosa. Luego, con un intervalo de una semana, se efectuaron las pruebas de tolerancia con dos tipos de desayunos, elaborados con alimentos de uso común en nuestro medio y cuya principal diferencia fue el tipo de carbohidrato. A los 0, 30, 60 y 120 minutos se cuantificó la concentración de glucosa, por el método de glucosa-oxidasa y la insulina por radioinmunoanálisis. Se calculó el área bajo la curva para la respuesta de glucosa e insulina. Para el análisis estadístico se aplicó un análisis de varianza y las pruebas post-test, para determinar la diferencia entre los grupos. Resultados: Se observó que la respuesta de glucosa con el desayuno 1 fue significativamente menor (p<0,05) a los 30 y 60 minutos y con el desayuno 2 a los 60 minutos (p<0.05) en comparación con la obtenida con la PTGO. El área bajo la curva (ABC) de glucemia no fue diferente entre los 2 tipos de desayunos y fue significativamente menor que con la PTGO. La respuesta de insulina fue significativamente mas baja a los 120 minutos (p<0.05) con el desayuno 1 (arepa) en relación con el desayuno 2 (pan) y con la PTGO. El ABC de insulinemia no fue diferente entre los desayunos y la PTGO. Conclusiones: La respuesta de glucemia postprandial con mezcla de nutrientes es menor que la obtenida con la PTGO, por lo que no debe ser usada con fines diagnósticos.
Objectives: To compare the glycemic and insulinemic responses of two breakfasts with the standard oral glucose tolerance test (OGTT). Methods: In 14 healthy subjects, the OGTT with 75 g of glucose was performed. After an interval of one week, tolerance tests with two types of breakfasts elaborated with common food in our country, and whose main difference was the type of carbohydrate, were carried out. At 0, 30, 60 and 120 minutes, glucose concentration by the glucose oxidase method and insulin by radioimmunoassay were measured. Areas under the curve (AUC) for glucose and insulin response were calculated. An analysis of variance test was applied to determine the difference between the groups. Results: It was noted that the glucose response to breakfast 1 was significantly lower (p <0.05) at 30 and 60 minutes and to breakfast 2 at 60 minutes (p <0.05) compared with that obtained with OGTT. The glucose AUC was not different between the 2 types of breakfasts and was significantly lower than the obtained with OGTT. The insulin response was significantly lower at 120 minutes (p <0.05) with breakfast 1 (arepa) in relation to breakfast 2 (bread) and the OGTT. The insulin AUC was not different between breakfasts and the OGTT. Conclusions: The postprandial blood glucose response to mix of nutrients is lower than that obtained with the OGTT, so it should not be used for diagnostic purposes.
RÉSUMÉ
A cada dia cresce o interesse por alimentos ricos em carboidratos não disponíveis em virtude da relação inversa entre seu consumo e o risco de doenças crônicas não transmissíveis (DCNT). No presente trabalho, foi avaliado o potencial fisiológico da farinha de banana verde (FBV) como ingrediente funcional. Em ratos adultos, foi realizado ensaio de média duração (28 dias) para avaliação do efeito trófico da FBV sobre o intestino grosso e de parâmetros relacionados à tolerância à glicose. Em humanos, foram realizados ensaios clínicos de curta e média duração para avaliação dos efeitos sobre resposta glicêmica; liberação de hormônios gastrintestinais relacionados à saciedade; status antioxidante; fome e saciedade; e funcionamento intestinal. A FBV foi produzida com banana verde, Musa acuminata, de acordo com patente depositada pelo grupo (Patente (RPI - 1941), 2008). A FBV é uma fonte concentrada de carboidratos não disponíveis, com 56% de AR e 8% de FAT na base integral. A adição de FBV nas rações provocou efeito trófico no ceco dos animais, evidenciado por aumento no índice metafásico, número de células da cripta e profundidade das criptas. Além disso, a ração com FBV proporcionou melhora nos parâmetros relacionados à tolerância à glicose. Em voluntários saudáveis, a ingestão de uma única refeição adicionada de 8 g de FBV proporcionou aumento na saciedade e boa correlação entre os parâmetros fome/saciedade e níveis plasmáticos de grelina e insulina, melhorou o funcionamento intestinal, além de resultar em alta fermentabilidade in vitro em relação à lactulose. Após ingestão diária da FBV por 14 dias, os resultados da ingestão de RC0 (refeição controle antes do tratamento) e de RC14 (RC0 após 14 dias de tratamento) mostraram que ocorre melhora na tolerância à glicose, evidenciada pela menor liberação de insulina durante o GTT. O efeito positivo sobre funcionamento intestinal, sobre saciedade e sobre liberação de hormônios gastrintestinais no plasma permaneceu...
The study of unavailable carbohydrates has been of great concern due to their inverse relation with the risk for non-transmissible chronic diseases (NTCD). In the present study, the functional potential of unripe banana flour (UBF) was evaluated. In rats, a medium-term assay was carried in order to evaluate parameters related to glucose tolerance and the trophic effect of UBF on the large bowel. In healthy volunteers, short and medium-term clinical assays were carried to evaluate the effects of UBF on glycemic response; release of gastrointestinal hormones related to satiety (ghrelin, leptin and insulin); antioxidant status; hunger and satiety; and intestinal health. UBF was produced with unripe banana, Musa acuminata, subgroup Cavendish, maturation stage I, in industrial scale and according to a patent deposited by the group (Patent (RPI - 1941), 2008). UBF is a concentrated source of unavailable carbohydrates, with 56% RS and 8% DF (wet weight). Adding UBF in rat rations resulted in a trophic effect in the animals' cecum, which was evidenced by increase in the metaphasic index, number of crypt cells and crypt depth. Moreover, the ration with UBF resulted in better glucose tolerance parameters. In healthy volunteers, adding UBF (8 g) to an only meal provided significant satiety and good correlation between the parameters hunger/ satiety and plasmatic levels of ghrelin and insulin, improved bowel habit, as well as resulted in high in vitro fermentability in relation to lactulose. After daily intake of UBF for 14 days, the results of the intake of RC0 (control meal before treatment) and RC14 (RC0 after 14 days treatment) showed that there is a positive post-prandial variation in the plasmatic concentrations of gastrointestinal hormones, as well as improvement in glucose tolerance, evidenced by lower insulin release during GTT. The positive effect on bowel habit, satiety and release of gastrointestinal hormones in plasma was kept after prolonged intake of UBF...